0 results available. Select is focused ,type to refine list, press Down to open the menu,
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company ...
The following section summarizes insights on Gilead Sciences Inc's Beneish M-Score:
We've identified the following companies as similar to Gilead Sciences Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Beneish M-Score in the risk category include:
A statistical score that uses financial ratios to identify whether a company has manipulated its earnings
The Beneish M-Score statistical score that uses financial ratios to identify whether a company has manipulated its earnings. Gilead Sciences’s Beneish M-Score of −3.52 implies the company is not a likely earnings manipulator.
The Beneish M-Score outlines eight financial ratios required to calculate the score:
1) Days Sales in Receivables Index (DSRI)
DSRI = (Net Receivablest / Salest) / (Net Receivablest-1 / Salest-1)
2) Gross Margin Index (GMI)
GMI = [(Salest-1 - COGSt-1) / Salest-1] / [(Salest - COGSt) / Salest]
3) Asset Quality Index (AQI)
AQI = [(Total Assets - Current Assetst - PP&Et) / Total Assetst] / [(Total Assets - Current Assetst-1 - PP&Et-1) / Total Assetst-1]
4) Sales Growth Index (SGI)
SGI = Salest / Salest-1
5) Depreciation Index (DEPI)
DEPI = (Depreciationt-1/ (PP&Et-1 + Depreciationt-1)) / (Depreciationt / (PP&Et + Depreciationt))
6) Sales General and Administrative Expenses Index (SGAI)
SGAI = (SG&A Expenset / Salest) / (SG&A Expenset-1 / Salest-1)
7) Leverage Index (LVGI)
LVGI = [(Current Liabilitiest + Total Long Term Debtt) / Total Assetst] / [(Current Liabilitiest-1 + Total Long Term Debtt-1) / Total Assetst-1]
8) Total Accruals to Total Assets (TATA)
TATA = (Income from Continuing Operationst - Cash Flows from Operationst) / Total Assetst
After computing the eight variables outlined above, they can be weighted together using the following multivariate model to calculate the score:
Beneish M-Score =
-4.84
(+) 0.92 × DSRI
(+) 0.528 × GMI
(+) 0.404 × AQI
(+) 0.892 × SGI
(+) 0.115 × DEPI
(+) -0.172 × SGAI
(+) 4.679 × TATA
(+) -0.327 × LVGI
The chart above depicts the distribution of beneish m-score for companies operating in the Healthcare sector in the Developed economic region. Over 1,550 companies were considered in this analysis, and 1,491 had meaningful values. The average beneish m-score of companies in the sector is -2.34 with a standard deviation of 4.10.
Gilead Sciences Inc's Beneish M-Score of -3.52 ranks in the 20.5% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,553 |
| Included Constituents | 1,491 |
| Min | -17.19 |
| Max | 29.80 |
| Median | -2.70 |
| Mean | -2.34 |
| Standard Deviation | 4.10 |
You can find companies with similar beneish m-score using this stock screener.